Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) EBT (2019 - 2025)

Historic EBT for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$2.0 million.

  • Eton Pharmaceuticals' EBT fell 49021.96% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.5 million, marking a year-over-year decrease of 2218.24%. This contributed to the annual value of -$3.8 million for FY2024, which is 45268.51% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported EBT of -$2.0 million as of Q3 2025, which was down 49021.96% from -$2.5 million recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' EBT registered a high of $5.1 million during Q1 2021, and its lowest value of -$6.1 million during Q3 2021.
  • Over the past 5 years, Eton Pharmaceuticals' median EBT value was -$1.6 million (recorded in 2022), while the average stood at -$1.1 million.
  • Per our database at Business Quant, Eton Pharmaceuticals' EBT soared by 39261.87% in 2023 and then tumbled by 49021.96% in 2025.
  • Eton Pharmaceuticals' EBT (Quarter) stood at $1.0 million in 2021, then fell by 12.22% to $912000.0 in 2022, then crashed by 320.29% to -$2.0 million in 2023, then skyrocketed by 74.56% to -$511000.0 in 2024, then crashed by 282.58% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, -$2.5 million for Q2 2025, and -$1.5 million during Q1 2025.